Pods, don't take this as sticking up for MBE, I'm not happy at all with them. Below it states the second half they will be cutting DCB Marketing to conserve cash. Revenue could have been higher if they wanted to burn cash but have made the right call. Lucky this business can largely be turned off like a tap by simply reducing marketing spending. Staff costs and office rent etc will need to be paid for still but It looks the marketing spend alone is the big cash burn part of DCB. As I said lucky for MBE they don't have inventory, mainly staff and office costs.
1H group EBITDA met guidance $2.1m with revenue of $27.1m. FY Company's revenue is estimated to be $52m and EBITDA to be between $5m and $6m. Its estimates FY cash at bank as at 30 June 2017 will improve to $12m, (from $8m), sufficiently funding current operations.
Reduction of DCB marketing spend, whilst boosting the Company's cash position, is estimated to impact FY2017 revenue by $13m.
- Forums
- ASX - By Stock
- IMS
- MBE Oversold
MBE Oversold, page-397
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMS (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online